NDC 50991-0323-25: Foltrate Folic Acid and Cyanocobalamin 500; 1 ug; mg Tablet, Film Coated
This is a package of Foltrate Folic Acid and Cyanocobalamin 500; 1 ug; mg Tablet, Film Coated from Poly Pharmaceuticals, Inc., no longer marketed, no longer in the FDA NDC Directory.
NDC database record
One package, one record: these facts belong to NDC 50991-323-25 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 50991 labeler · 323 product · 25 package
- Barcode (UPC-A, from the NDC)
- 3 5099132325 2
- FDA record last changed
- Mar 13, 2024
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Marketing end | Status |
|---|---|---|---|---|---|---|
| 50991-0323-01 50991-323-01 Main listing | 100 TABLET, FILM COATED in 1 BOTTLE | $0.6640 / ea | $66.40 | 2010-08-26 | — | Discontinued by firm |
| 50991-0323-25 You're viewing this | 12 BLISTER PACK in 1 CARTON / 2 TABLET, FILM COATED in 1 BLISTER PACK | — | — | 2010-08-26 | — | Discontinued by firm |
Pack size FAQ
What quantity is in this package?
What NDC number is used to bill for this package of Foltrate Folic Acid and Cyanocobalamin 500; 1 ug; mg Tablet, Film Coated?
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Foltrate 500; 1 ug/1; mgthis 50991-0323-25 | Poly | 2 tablets | — | — | Discontinued | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Poly Pharmaceuticals, Inc. labeler code 50991
- Polytussin DM Dextromethorphan HBr, Phenylephrine HCl, Pyrilamine Maleate 7.5 mg/5mL; 12.5 mg/5mL; 5 mg/5mL Syrup NDC 50991-132-05
- Endal Triprolidine HCl, Dextromethorphan HBr 1.25 mg/5mL; 10 mg/5mL Liquid NDC 50991-136-05
- DURATUSS DM Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide and Pseudoephedrine Hydrochloride 1 mg/5mL; 10 mg/5mL; 30 mg/5mL Liquid NDC 50991-142-16
- Poly-Vent IR Guaifenesin and Pseudoephedrine HCl 380 mg; 60 mg Tablet NDC 50991-212-01
- Poly-Vent DM Dextromethorphan HBr, Guaifenesin and Pseudoephedrine HCl 60 mg; 380 mg; 20 mg Tablet NDC 50991-214-01
- POLY-HIST DM DEXCHLORPHENIRAMINE MALEATE AND DEXTROMETHORPHAN HBR 10 mg/5mL; 1 mg/5mL Liquid NDC 50991-271-15
- ALAHIST DM Dextromethorphan HBr, Pheniramine Maleate, Phenylephrine HCl 10 mg/5mL; 5 mg/5mL; 12.5 mg/5mL Liquid NDC 50991-444-15
- Duraflu ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PSEUDOEPHEDRINE HCl 60 mg; 325 mg; 20 mg; 200 mg Tablet NDC 50991-535-01
- Duratuss AC Codeine Phosphate, Dexbrompheniramine Maleate 10 mg/5mL; 1 mg/5mL Liquid NDC 50991-540-16
- Poly Hist Forte Doxylamine Succinate and Phenylephrine Hydrochloride 10.5 mg; 10 mg Tablet NDC 50991-626-01
- Deconex IR Guaifenesin and Phenylephrine HCl 385 mg; 10 mg Tablet NDC 50991-736-02
- DECONEX DMX Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride 17.5 mg; 400 mg; 10 mg Tablet NDC 50991-740-01
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2026 (Q1)
About this NDC listing & data coverage
Listed without an FDA application
This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC The FDA label for this product carries no photos. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |